Ad is loading...
ALVR
Price
$0.57
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
81 days until earnings call
SNDX
Price
$16.09
Change
+$0.49 (+3.14%)
Updated
Nov 22 closing price
102 days until earnings call
Ad is loading...

ALVR vs SNDX

Header iconALVR vs SNDX Comparison
Open Charts ALVR vs SNDXBanner chart's image
AlloVir
Price$0.57
Change-$0.00 (-0.00%)
Volume$322.44K
CapitalizationN/A
Syndax Pharmaceuticals
Price$16.09
Change+$0.49 (+3.14%)
Volume$1.47M
CapitalizationN/A
ALVR vs SNDX Comparison Chart
Loading...
ALVR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALVR vs. SNDX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVR is a Hold and SNDX is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ALVR: $0.55 vs. SNDX: $16.09)
Brand notoriety: ALVR and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALVR: 80% vs. SNDX: 99%
Market capitalization -- ALVR: $63.53M vs. SNDX: $1.37B
ALVR [@Biotechnology] is valued at $63.53M. SNDX’s [@Biotechnology] market capitalization is $1.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVR’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • ALVR’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than ALVR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVR’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • ALVR’s TA Score: 5 bullish, 5 bearish.
  • SNDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALVR and SNDX are a good buy in the short-term.

Price Growth

ALVR (@Biotechnology) experienced а -3.36% price change this week, while SNDX (@Biotechnology) price change was +1.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

ALVR is expected to report earnings on Feb 12, 2025.

SNDX is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.37B) has a higher market cap than ALVR($63.5M). ALVR YTD gains are higher at: -19.109 vs. SNDX (-25.544). ALVR has higher annual earnings (EBITDA): -79.43M vs. SNDX (-296.86M). SNDX has more cash in the bank: 406M vs. ALVR (122M). ALVR has less debt than SNDX: ALVR (0) vs SNDX (854K). SNDX has higher revenues than ALVR: SNDX (16M) vs ALVR (0).
ALVRSNDXALVR / SNDX
Capitalization63.5M1.37B5%
EBITDA-79.43M-296.86M27%
Gain YTD-19.109-25.54475%
P/E RatioN/AN/A-
Revenue016M-
Total Cash122M406M30%
Total Debt0854K-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVRSNDX
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 11 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
ALVR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSMAX11.690.17
+1.48%
SEI Small/Mid Cap Equity A (SIIT)
SSDSX38.070.49
+1.30%
DWS Small Cap Growth S
OBGIX31.720.25
+0.79%
Oberweis Global Opportunities Instl
SVLCX31.900.19
+0.60%
Columbia Select Large Cap Value C
MKLOX19.790.05
+0.25%
BlackRock Global Allocation K

ALVR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALVR has been loosely correlated with MDGL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALVR jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVR
1D Price
Change %
ALVR100%
-3.53%
MDGL - ALVR
46%
Loosely correlated
+5.53%
CRSP - ALVR
40%
Loosely correlated
+3.43%
SNDX - ALVR
39%
Loosely correlated
+3.14%
ALLO - ALVR
39%
Loosely correlated
+4.74%
XNCR - ALVR
38%
Loosely correlated
+3.78%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+3.14%
ABOS - SNDX
48%
Loosely correlated
+2.60%
RAPT - SNDX
45%
Loosely correlated
+2.86%
BEAM - SNDX
45%
Loosely correlated
+6.23%
VCYT - SNDX
45%
Loosely correlated
+1.67%
ALEC - SNDX
43%
Loosely correlated
+4.79%
More